Explore related pages
Related company profiles:
News
Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025 - Yahoo Finance
Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025 Yahoo Finance
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Geron Corporation Announces Executive Leadership Transitions and Appointments - GlobeNewswire
Geron Corporation Announces Executive Leadership Transitions and Appointments GlobeNewswire
Nearly 1M Shares: Geron Corporation's Major Equity Grant Package Draws 16 New Biotech Talents - Stock Titan
Nearly 1M Shares: Geron Corporation's Major Equity Grant Package Draws 16 New Biotech Talents Stock Titan
Geron to Participate in the 2025 Wells Fargo Healthcare Conference - Business Wire
Geron to Participate in the 2025 Wells Fargo Healthcare Conference Business Wire
Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights - Yahoo Finance
Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights Yahoo Finance
Geron Appoints Harout Semerjian as President and Chief Executive Officer - Business Wire
Geron Appoints Harout Semerjian as President and Chief Executive Officer Business Wire
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Yahoo Finance
Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights - Business Wire
Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights Business Wire
Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program - Business Wire
Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program Business Wire
Geron Corporation Announces Departure of Chief Executive Officer - Business Wire
Geron Corporation Announces Departure of Chief Executive Officer Business Wire
Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS - Business Wire
Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS Business Wire
Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (imetelstat) in Myeloid Hematologic Malignancies - Yahoo Finance
Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (imetelstat) in Myeloid Hematologic Malignancies Yahoo Finance
Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors - Business Wire
Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors Business Wire
FDA Approves Geron Corporation’s Rytelo to Treat Adults with Lower-Risk Myelodysplastic Syndromes - Pharmaceutical Executive
FDA Approves Geron Corporation’s Rytelo to Treat Adults with Lower-Risk Myelodysplastic Syndromes Pharmaceutical Executive
Geron to Announce Third Quarter 2023 Financial Results on November 2, - Business Wire
Geron to Announce Third Quarter 2023 Financial Results on November 2, Business Wire
Geron to Announce First Quarter 2023 Financial Results on May 11, 2023 - Business Wire
Geron to Announce First Quarter 2023 Financial Results on May 11, 2023 Business Wire
Geron to Announce Fourth Quarter and Full-Year 2022 Financial Results on March 16, 2023 - Business Wire
Geron to Announce Fourth Quarter and Full-Year 2022 Financial Results on March 16, 2023 Business Wire
Geron Announces Conference Call for Top-Line Results from IMerge Phase 3 - Business Wire
Geron Announces Conference Call for Top-Line Results from IMerge Phase 3 Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Geron Corporation Reports Business Highlights and Third Quarter 2023 Financial Results - Stock Titan
Geron Corporation Reports Business Highlights and Third Quarter 2023 Financial Results Stock Titan
Geron Announces Experienced Commercial Leadership Hired for Planned Commercial Launch of Imetelstat in the U.S. - Business Wire
Geron Announces Experienced Commercial Leadership Hired for Planned Commercial Launch of Imetelstat in the U.S. Business Wire
Geron Announces Data Presentations from IMerge Phase 3 Evaluating Imetelstat in Lower Risk MDS at Society of Hematologic Oncology Annual Meeting - Stock Titan
Geron Announces Data Presentations from IMerge Phase 3 Evaluating Imetelstat in Lower Risk MDS at Society of Hematologic Oncology Annual Meeting Stock Titan
Geron Appoints Biopharma Veteran John F. McDonald to Board of Directors - FinancialContent
Geron Appoints Biopharma Veteran John F. McDonald to Board of Directors FinancialContent
Top Geron Corporation Employees
-
Jeff Ryel
20+ Years Of Experience In The Pharmaceutical Clinical Industry.
Scottsdale, Arizona, United States, United States4pfizer.com, jeffryel.com, pumabiotechnology.com, geron.com -
Stephanie Dellari
n/a
Menlo Park, California, United States, United States1geron.com -
Dawn Liu Winn
n/a
United States, United States3yahoo.com, gilead.com, gilead.com5 +165078XXXXX
-
Rachel Williams
n/a
San Diego Metropolitan Area, United States4gmail.com, alliant.com, dexcom.com, dermtech.com2 +185887XXXXX
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.